Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Michael Hall

Email
Center AffiliationsCancer Prevention and Control

Publications (45) (print view)

no pagination
Dotan E, Li T, Hall MJ, Meropol NJ, Beck JR, Wong YN. Oncologists' response to new data regarding the use of epidermal growth factor receptor inhibitors in colorectal cancer. J Oncol Pract. 2014 Sep;10(5):308-14.   PMCID: Pmc4161728
Hall MJ. Conflicted confidence: academic oncologists' views on multiplex pharmacogenomic testing. J Clin Oncol. 2014 May;32(13):1290-2.   PMCID: Comment
Hall MJ, Forman AD, Pilarski R, Wiesner G, Giri VN. Gene Panel Testing for Inherited Cancer Risk. J Natl Compr Canc Netw. 2014 Sep;12(9):1339-46.
Hall MJ, Herda MM, Handorf EA, Rybak CC, Keleher CA, Siemon M, Daly MB. Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study. Genet Med. 2014 Nov;16(11):854-61.   PMCID: PMC4216634
Konski A, Meyer JE, Joiner M, Hall MJ, Philip P, Shields A, McSpadden E, Choi M, Adaire B, Duncan G, Meropol NJ, Cescon TP, Cohen SJ. Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer. Radiother Oncol. 2014 Oct;113(1):35-40.
Matro JM, Ruth KJ, Wong YN, McCully KC, Rybak CM, Meropol NJ, Hall MJ. Cost Sharing and Hereditary Cancer Risk: Predictors of Willingness-to-Pay for Genetic Testing. Journal of Genetic Counseling. 2014 Dec;23(6):1002-11.   PMCID: 4420173
Thomay AA, Nagorney DM, Cohen SJ, Sigurdson ER, Truty MJ, Burtness B, Hall MJ, Chun YS. Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer. J Gastrointest Surg. 2014 Jan;18(1):69-74.
Jones KA, Kim PD, Patel BB, Kelsen SG, Braverman A, Swinton DJ, Gafken PR, Jones LA, Lane WS, Neveu JM, Leung HC, Shaffer SA, Leszyk JD, Stanley BA, Fox TE, Stanley A, Hall MJ, Hampel H, South CD, de la Chapelle A, Burt RW, Jones DA, Kopelovich L, Yeung AT. Immunodepletion Plasma Proteomics by TripleTOF 5600 and Orbitrap Elite/LTQ-Orbitrap Velos/Q Exactive Mass Spectrometers. Journal of Proteome Research. 2013 Oct;12(10):4351-65.   PMCID: PMC 3817719
Adonizio C, Gazzillo M, Knezetic J, Snyder C, Lynch HT, Rybak C, Hall MJ, Lowstuter K, Eggington J, Morris GJ. Thirty-nine-year-old with familial colon cancer, and variant of undetermined significance in MSH6. Semin Oncol. 2012 Apr;39(2):125-31.   PMCID: not NIH funded - case report
Hall MJ, Manne SL, Myers RE, Keenan EM, Balshem AM, Weinberg DS. Predictors of patient uptake of colorectal cancer gene environment risk assessment. Genome Med. 2012 Nov 29;4(11):92.   PMCID: PMC3580425
Hall MJ, Ruth K, Giri VN. Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program. Cancer. 2012 Jan;118(2):478-84.   PMCID: PMC3195866
Kindler HL, Wroblewski K, Wallace JA, Hall MJ, Locker G, Nattam S, Agamah E, Stadler WM, Vokes EE. Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium. Investigational New Drugs. 2012 Feb;30(1):382-6.
Chun YS, Cooper HS, Cohen SJ, Konski A, Burtness B, Denlinger CS, Astsaturov I, Hall MJ, Hoffman JP. Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer. Annals of Surgical Oncology. 2011 Dec;18(13):3601-7.   PMCID: not NIH funded
Hall MJ, Manne SL, Winkel G, Chung DS, Weinberg DS, Meropol NJ. Effects of a Decision Support Intervention on Decisional Conflict Associated with Microsatellite Instability Testing. Cancer Epidemiology Biomarkers & Prevention. 2011 Feb;20(2):249-54.   PMCID: PMC3076798
Rybak C, Hall MJ. Interpretation of genetic testing for lynch syndrome in patients with putative familial colorectal cancer. J Natl Compr Canc Netw. 2011 Nov;9(11):1311-20.   PMCID: not NIH funded
Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP. Defining Venous Involvement in Borderline Resectable Pancreatic Cancer. Annals of Surgical Oncology. 2010 Nov;17(11):2832-8.   PMCID: no NIH funding
Hall MJ. Counterpoint: Implementing Population Genetic Screening for Lynch Syndrome Among Newly Diagnosed Colorectal Cancer Patients-Will the Ends Justify the Means?. Journal of the National Comprehensive Cancer Network. 2010 May;8(5):606-11.
Hall MJ. Counterpoint: implementing population genetic screening for lynch syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?. J Natl Compr Canc Netw. 2010 May;8(5):606-11.   PMCID: not NIH funded
Hall MJ, Egleston B, Miller SM, Buzaglo JS, Millard J, Ridgway C, Damjanov N, Sprandio JD, Meropol NJ. Barriers to participation in cancer prevention clinical trials. Acta Oncologica. 2010 Aug;49(6):757-66.   PMCID: PMC2901417
Hall MJ, Reid JE, Wenstrup RJ. Prevalence of BRCA1 and BRCA2 Mutations in Women with Breast Carcinoma In Situ and Referred for Genetic Testing. Cancer prevention research (Philadelphia, Pa). 2010 Dec;3(12):1579-85.   PMCID: PMC3005273
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Michael Hall Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Wednesday, September 06, 2017